The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The CEO of UnitedHealth Group defended the company's role in the U.S. health care system days after a report said the company ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
After almost seven decades of providing medication and more to the people of San Angelo, Medical Arts Pharmacy is shutting ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback